Bitte wählen Sie:

Universitätsklinikum Essen
Direkteinstieg:
Forschung

Ausgewählte Publikationen

Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
Schuh, A; Ayvaz, G; Baldeschi, L; Baretić, M; Bechtold, D; Boschi, A; Brix, TH; Burlacu, M-C; Ciric, J; Covelli, D; Currò, N; Donati, S; Eckstein, AK; Fichter, N; Führer, D; Horn, M; Jabłońska-Pawlak, A; Juri M, Jelena; K, George J; Konuk, O; Langbein, A; Lanzolla, G; Marcocci, C; Marinò, M; Miśkiewicz, Piotr; B, Biljana N; Pérez-Lázaro, A; Pérez-López, M; Ponto, KA; Quinn, A; Rudofsky, G; Salvi, M; Schittkowski, MP; Tanda, ML; Toruner, F; Vaidya, B; Hintschich, CR
2023. Br J Ophthalmol doi: 10.1136/bjo-2022-322442

Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases
Kleinhans, M; Albrecht, LJ; Benson, S; Fuhrer, D; Dissemond, J; Tan, S
2023. J Diabetes Sci Technol doi: 10.1177/19322968221147937

Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
Hönes, GS; Sivakumar, RG; Hoppe, C; König, J; Führer, D; Moeller, LC
Int J Mol Sci 23(22):13714. doi: 10.3390/ijms232213714

Cardioprotection by Hypothyroidism Is Not Mediated by Favorable Hemodynamics-Role of Canonical Thyroid Hormone Receptor Alpha Signaling
Pape, J; Kerp, H; Lieder, HR; Geist, D; Hönes, GS; Moeller, LC; Kleinbongard, P; Führer, D
2022. Int J Mol Sci 23(21):13340. doi: 10.3390/ijms232113340

Artificial Sepsis: Think Twice Before Pausing Therapy
Mathew, A; Führer, D; Lahner, H
2022. Am J Med 135(3):e73-e74. doi: 10.1016/j.amjmed.2021.10.006

Hepatobiliary Thyroid Hormone Deficiency Impacts Bile Acid Hydrophilicity and Aquaporins in Cholestatic C57BL/6J Mice
Kube, I; Kowalczyk, M; Hofmann, U; Ghallab, A; Hengstler, JG; Führer, D; Zwanziger, D
2022. Int J Mol Sci 23(20):12355. doi: 10.3390/ijms232012355

Implications of a HbA1c based diabetes screening on prevalence and impact of dysglycemia in patients with COVID-19
van Baal, L; Reinold, J; Benson, S; Diehl, A; Witzke, O; Fuhrer, D; Tan, S
2022. J Clin Endocrinol Metab dgac590. doi: 10.1210/clinem/dgac590

[Regional Differences in Thyroid Function Parameters: A Comparison of European Cohort Studies]
Girschik, C; Muchalla, P; Kowall, B; Zwanziger, D; Erbel, R; Ittermann, T; Meisinger, C; Stang, A; Jöckel, K-H; Führer, D
2022. Gesundheitswesen doi: 10.1055/a-1806-0707

Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
Lahner, H; Mathew, A; Klocker, AL; Unger, N; Theysohn, J; Rekowski, J; Jöckel, K-H; Theurer, S; Schmid, KW; Herrmann, K; Führer, D
2022. Endocrine 75(1):293-302. doi: 10.1007/s12020-021-02859-y

CT-derived body composition analysis could possibly replace DXA and BIA to monitor NET-patients
Kroll, L; Mathew, A; Baldini, G; Hosch, R; Koitka, S; Kleesiek, J; Rischpler, C; Haubold, J; Fuhrer, D; Nensa, F; Lahner, H
2022. Sci Rep 12(1):13419. doi: 10.1038/s41598-022-17611-3

A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) Collaborative
Vardarli, I; Brandenburg, T; Hegedüs, L; Attanasio, R; Nagy, E; Papini, E; Perros, P; Weidemann, F; Herrmann, K; Führer, D
2022. Exp Clin Endocrinol Diabetes 130(9):577-586. doi: 10.1055/a-1832-0644

Tentative Application of a Streamlined Protocol to Determine Organ-Specific Regulations of Deiodinase 1 and Dehalogenase Activities as Readouts of the Hypothalamus-Pituitary-Thyroid-Periphery-Axis
Renko, K; Kerp, H; Pape, J; Rijntjes, E; Burgdorf, T; Führer, D; Köhrle, J
2022. Front Toxicol 21;4:822993. doi: 10.3389/ftox.2022.822993

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era
Capdevila, J; Awada, A; Führer, D; Leboulleux, S; Pauwels, P
2022. Cancer Treat Rev 106:102380. doi: 10.1016/j.ctrv.2022.102380

Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use
Tsiomidou, S; Pamporaki, C; Geroula, A; van Baal, L; Weber, F; Dralle, H; Schmid, K.W.; Führer, D; Unger, N
2022. Clin Endocrinol 97(5):541-550. doi: 10.1111/cen.14724

The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it
Wenzek, C; Boelen, A; Westendorf, A.M.; Engel, D.R.; Moeller, L.C.; Führer, D
2022. Eur Thyroid J 1;11(1):e210046. doi: 10.1530/EJE-21-1171

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
Pacini F, Fuhrer D, Elisei R, Handkiewicz-Junak D, Leboulleux S, Luster M, Schlumberger M, Smit JW.
2022. Eur Thyroid J 11(1). doi: 10.1530/ETJ-21-0046

 

 

Univ.-Prof. Dr. Dr. med. Dagmar Führer-Sakel
Ansprechpartner

Univ.-Prof. Dr. Dr. med. Dagmar Führer-Sakel

Direktorin

+49 (0) 201 - 723 - 6401 E-Mail schreiben